Clorotepine mesylate

• CAT Number: I024991
• CAS Number: 42505-79-3
• Molecular Formula: C20H25ClN2O3S2
• Molecular Weight: 441
• Purity: 98%
• Synonyms: Clorotepine mesylate; Clorotepin methanesulfonate
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 1-(8-Chloro-10,11-dihydrodibenzo(b,f)thiepin-10-yl)-4-methylpiperazinium methanesulphonate
• InChI: InChI=1S/C19H21ClN2S.CH4O3S/c1-21-8-10-22(11-9-21)17-12-14-4-2-3-5-18(14)23-19-7-6-15(20)13-16(17)19;1-5(2,3)4/h2-7,13,17H,8-12H2,1H3;1H3,(H,2,3,4)
• InChIKey: XQRUOHZMMIUQSB-UHFFFAOYSA-N
• SMILES: CN1CC[NH+](C2CC3=CC=CC=C3SC4=CC=C(Cl)C=C24)CC1.CS(=O)([O-])=O

Clorotepine mesylate is the salt form of Clorotepine (free base), a major tranquilizer with action similar to those of the phenothiazines; used in schizophrenic & manic psychoses.

Reference

1: Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10. PMID: 7908055.
2: Viswanathan G, Yadav S, Raghunand TR. Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00425-17. doi: 10.1128/AAC.00425-17. PMID: 28438925; PMCID: PMC5487644.
3: Risgaard R, Ettrup A, Balle T, Dyssegaard A, Hansen HD, Lehel S, Madsen J, Pedersen H, Püschl A, Badolo L, Bang-Andersen B, Knudsen GM, Kristensen JL. Radiolabelling and PET brain imaging of the α₁-adrenoceptor antagonist Lu AE43936. Nucl Med Biol. 2013 Jan;40(1):135-40. doi: 10.1016/j.nucmedbio.2012.09.010. Epub 2012 Nov 17. PMID: 23165140.
4: Nisa S, Blokpoel MC, Robertson BD, Tyndall JD, Lun S, Bishai WR, O’Toole R. Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery. J Antimicrob Chemother. 2010 Nov;65(11):2347-58. doi: 10.1093/jac/dkq311. Epub 2010 Sep 1. PMID: 20810423; PMCID: PMC2980951.
5: Kristensen JL, Püschl A, Jensen M, Risgaard R, Christoffersen CT, Bang- Andersen B, Balle T. Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors. J Med Chem. 2010 Oct 14;53(19):7021-34. doi: 10.1021/jm100652h. PMID: 20857909.
6: Tehan BG, Lloyd EJ, Wong MG. Molecular field analysis of clozapine analogs in the development of a pharmacophore model of antipsychotic drug action. J Mol Graph Model. 2001;19(5):417-26, 468. doi: 10.1016/s1093-3263(00)00101-7. PMID: 11552690.
7: Zapletálek M, Zbytovský J, Kindernayová H. Clinical and experimental study of oxyprothepine. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1980;23(4):487-90. PMID: 6111116.
8: Metysová J, Metys J, Dlabac A, Kazdová E, Valchár M. Pharmacological properties of a potent neuroleptic drug octoclothepin. Acta Biol Med Ger. 1980;39(6):723-40. PMID: 6893891.
9: Polák L, Molcan J. Clonidine in hyperkinetic children. Act Nerv Super (Praha). 1990 Mar;32(1):66-7. PMID: 1973018.
10: Bøgesø KP, Liljefors T, Arnt J, Hyttel J, Pedersen H. Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonists. J Med Chem. 1991 Jul;34(7):2023-30. doi: 10.1021/jm00111a015. PMID: 1676758.